微管和细胞分裂:在癌症治疗中潜在的药理学点
Jomon Sebastian1, Krishnan Rathinasamy2
1Department of Biotechnology, Cochin University of Science and Technology, Kochi, Kerala, India.
Current drug targets
|July 31, 2023
概括
微管对于细胞分裂至关重要,并作为癌症化疗的关键标. 发现新的微管抑制剂对于克服抗药性和癌症治疗中的毒性至关重要.
科学领域:
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 微管在细胞分裂 (线粒分裂) 中发挥着关键作用,是癌症化疗的验证标.
- 破坏微管的动态会导致线粒体的停止和亡,抑制癌细胞的增殖.
- 抗微管体剂在癌症治疗中被广泛使用,其向特定的结合部位,如菌素部位.
研究的目的:
- 审查微管子作为癌症治疗中药理学标的重要性.
- 突出目前微管向药物的局限性,包括毒性和耐药性.
- 强调新型微管抑制剂的需要,并探索组合疗法策略.
主要方法:
- 对微管向药物及其作用机制的文献综述.
- 分析微管在线粒分裂和癌细胞增殖中的作用.
- 讨论已确定的药物结合部位 (维因布拉斯,塔克索尔,科尔奇辛) 和它们的影响.
主要成果:
- 微管破坏有效地抑制了癌细胞的生长,并诱导了细胞死亡.
- 素结合部位是一个重要的目标,但抑制剂面临毒性和耐药性的挑战.
- 组合疗法是一种有希望的策略,可以提高疗效并克服耐药性.
结论:
- 微管仍然是开发新抗癌药物的重要目标.
- 解决剂量限制性毒性和耐药性的问题对于有效的微管向癌症治疗至关重要.
- 对新型抑制剂和组合疗法的进一步研究是必要的,以有效地打击癌症.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Destabilization of Microtubules
2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Microtubule Formation
5.8K
Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation...
5.8K


